1. Age ≥ 18 years old |
2. Biopsy-proven IBD |
3. Impaired quality of life: Short IBD Questionnaire (SIBDQ) < 60 |
4. Symptoms: at least “some of the time” abdominal pain or bowel symptoms on SIBDQ |
5. Fluent in English |
6. Physically able to travel to study visits, within 1.5 h drive of study location |
Exclusion criteria
|
Health: |
1. Current ileostomy, colostomy, ileoanal pouch, ileorectal anastomosis, or short bowel syndrome |
2. Other significant chronic physical disease (e.g., uncontrolled diabetes, advanced liver disease, cancer, kidney failure, uncontrolled cardiovascular disease, seizures, light-triggered migraines). |
3. Has a pacemaker or defibrillator (potential interference from Fitbit device) |
4. Retinal pathology, cataracts, glaucoma, colorblindness |
5. Lifetime history of psychotic or bipolar disorders |
6. Suicidality in past 6 months |
7. Alcohol or substance use disorder in past 3 months (cannabis use ≤ 1/week ok) |
8. High risk for or diagnosed with obstructive sleep apnea and/or narcolepsy |
9. Severe hearing problem, cognitive impairment, not fluent in English |
10. Pregnant, trying to get pregnant, or breastfeeding |
11. Has a child or pet at home that disturbs sleep often |
12. Pending medical leave application at work, pending legal case/litigation |
13. Working shiftwork that affects sleep |
14. Recent (< 1 month) travel outside Eastern Time Zone |
15. Participating in another research study |
Medications: |
17. Taking photosensitizing medications to blue/green light (including methotrexate, sulfasalazine, promethazine, prochlorperazine) |
18. Taking melatonin |
19. Unstable non-IBD medication use 30 days prior to or during study |
20. Change of ≥ 10 mg/day of steroid medications use 30 days prior to or during study |
Light treatment: |
21. Average wake time is before 5:00am |
22. Unable to fit 1 h of light treatment into morning routine |
23. Previous use of light treatment device in the past year |